美股市場個股詳情
ACIU AC Immune
- 3.230
- -0.010-0.31%
交易中 11/21 13:14 (美東)
3.20億總市值-7146市盈率TTM
3.353最高價3.160最低價3.94萬股成交量3.230今開3.240昨收12.82萬成交額0.10%換手率虧損市盈率(靜)9894.31萬總股本5.14052周最高2.17市淨率1.28億流通值2.25052周最低--股息TTM3967.52萬流通股19.970歷史最高--股息率TTM5.94%振幅1.680歷史最低3.250平均價1股每手
關於AC Immune公司
AC Immune SA 是一家臨牀階段的生物製藥公司，專注於神經退行性疾病的研究。該公司利用其專有的技術平臺來發現、設計和開發針對與蛋白質錯誤摺疊相關的神經退行性疾病的預防、診斷和治療的新型專有小分子、抗體和疫苗。公司擁有一個業務部門。目前，公司將大部分資源集中在發現和開發針對錯誤摺疊蛋白的治療和診斷產品上。公司的管線產品包括ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056以及其他產品。
公司介紹
公司代碼ACIU
公司名稱AC Immune
上市日期2016/09/23
發行價格11.00
成立日期2003
CEODr. Andrea Pfeifer, PhD
所屬市場納斯達克
員工數量161
年結日12-31
公司地址EPFL Innovation Park,Building B
城市Lausanne
省份沃州
國家瑞士
郵編1015
電話41-21-345-91-21
董事高管
- 姓名
- 職務
- 年薪
- Dr. Andrea Pfeifer, PhD
- Chief Executive Officer and Director
- --
- Dr. Madiha Derouazi, PhD
- Chief Scientific Officer
- --
- Piergiorgio Donati
- Chief Technical Operations Officer
- --
- Howard Donovan
- Chief Human Resources Officer
- --
- Dr. Nuno Mendonça, M.D.
- Chief Medical Officer
- --
- Jean-Fabien Monin
- Chief Administrative Officer
- --
- Christopher Roberts
- Chief Financial Officer
- --
- Dr. Julien Rongere, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- Dr. Gary Waanders, PhD
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Dr. Olivier Sol, M.D.
- Vice President and Head of Clinical Development
- --
- Dr. Bojana Portmann, PhD
- Vice President, IP and Business Development
- --
- Mark Danton
- Senior Vice President Information Systems and Artificial Intelligence
- --
- Professor Dr. Monika Butler, PhD
- Vice Chairman of the Board and Director
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Dr. Werner Lanthaler, PhD
- Independent Director
- --
- Monica Shaw
- Independent Director
- --
- Dr. Roy Twyman, M.D.
- Independent Director
- --
- Professor Carl June, M.D.
- Independent Director
- --
- Dr. Julian Gray, PhD
- Clinical Advisor
- --
- Alexandre Caratsch
- General Counsel
- --
- Dr. Marie Kosco-Vilbois, PhD
- Scientific Advisor
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據